SCGE Workshop:
“Rethinking Clinical Delivery, Regulation, and Payment Models for Individualized Platform-Based Genome Editing Therapies”
Tuesday, September 29th, 2026 | 9:00 AM – 5:00 PM ET | Virtual
This workshop will bring together stakeholders across academia, industry, government, health economics, patient advocacy, and payer systems to examine how clinical trial design, clinical delivery models, and regulatory frameworks can be aligned with existing or novel reimbursement pathways to support sustainable and scalable delivery of genome editing therapies.
* Speakers, session titles, and times are subject to change*
**In-person attendance is limited and by invitation-only**
Session 1
Aligning Early Clinical Development with Regulatory and Reimbursement Expectations
Kiran Musunuru
University of Pennsylvania
Rebecca Ahrens-Nicklas
Children’s Hospital of Philadelphia
Timothy Yu
Boston Children’s Hospital/ Harvard Medical School
Sonia Vallabh
The Broad Institute
Session 2
Regulatory Frameworks for Evaluating Platform Based Therapies
Brian Stultz
U.S. Food & Drug Administration (FDA)
Jacob Bitterman
U.S. FDA
Aimee Magnarelli
U.S. FDA
Dan O’Connor
The Association of the British Pharmaceutical Industry
Session 3
Existing Pathways to Coverage and Reimbursement
Caroline Larson
Centers for Medicare and Medicaid Services (CMS)
Session 4
Exploring Innovative Approaches for Reimbursement for Genome Editing Therapies
Shyam Patel
California Institute for Regenerative Medicine (CIRM)
Winston Yan
The Broad Institute
Will Shrank
Aradigm
Jayson Slotnik
Health Policy Strategies, Inc.